Selma PEKGÖR, Mehmet Ali ERYILMAZ, İbrahim Fuat Kayıhan KAYA, Orhan KÜLAHCI

Evaluation of the relationship between insulin resistance and visceral adiposity index in patients with acne vulgaris

Background/aim: Acne vulgaris (AV) is a chronic inflammatory skin disease that is common among adolescents. Its etiology involves hormones, diet, genetics, and environmental factors. The aim of this study was to investigate the association between acne vulgaris and insulin resistance (IR) and visceral adiposity index (VAI). Materials and methods: The study included 184 individuals. Participants’ height, weight, waist and hip circumference and blood pressure were measured. Morning fasting blood was obtained from all participants for measuring glucose, insulin, triglyceride (TG), and cholesterol levels. The HOMA index and visceral adiposity index were calculated. The collected data were analyzed using statistical methods. Results: The patient and control groups exhibited similar age, gender, and body mass index (p > 0.05). There was no significant difference between the patient and control groups in HOMA index and VAI (p > 0.05). A positive correlation was observed between VAI and glucose, insulin, HOMA index, TG level, and waist circumference, whereas there was a negative correlation with high-density lipoprotein (HDL). Conclusion: Our study results demonstrated that IR and VAI were similar both in the AV and healthy control groups. There was no correlation between acne severity score and waist circumference, glucose, insulin, TG, HDL, HOMA index, and VAI. These results indicate that IR and visceral adipose tissue dysfunction alone are not effective in the development of acne.

PDF

___

1. Bhate K, Williams HC. Epidemiology of acne vulgaris. The British Journal of Dermatology 2013; 168 (3): 474-485. doi: 10.1111/bjd.12149
2. Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF et al. New developments in our understanding of acne pathogenesis and treatment. Experimental Dermatology 2009; 18 (10): 821-832. doi: 10.1111/j.1600-0625.2009.00890.x
3. Picardo M, Eichenfield LF, Tan J. Acne and rosacea. Dermatology and Therapy (Heidelb) 2017; 7 (Suppl 1): 43-52. doi: 10.1007/s13555-016-0168-8
4. Napolitano M, Megna M, Monfrecola G. Insulin resistance and skin diseases. The Scientific World Journal 2015; 2015: 479354. doi: 10.1155/2015/479354
5. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S et al. Visceral adiposity index (VAI): a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010; 33 (4): 920-922. doi:10.2337/dc09-1825
6. Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. International Journal of Dermatology 1997; 36 (6): 416-418. doi: 10.1046/j.1365-4362.1997.00099.x
7. Matthews DR, Hosker JP, Rudenski A, Bown EG, Naylor BA et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28 (7): 412-419. doi: 10.1007/BF00280883
8. Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999; 140 (9): 4089-4094. doi: 10.1210/endo.140.9.6957
9. Balachandrudu B, Niveditadevi V, Rani TP. Hormonal pathogenesis of acne–simplified. International Journal of Scientific Study 2015; 3: 183-185. doi: 10.17354/ijss/2015/181
10. Burris J, Rietkerk W, Shikany JM, Woolf K. Differences in dietary glycemic load and hormones in New York City adults with no and moderate/severe acne. Journal of the Academy of Nutrition and Dietetics 2017; 117 (9): 1375-1383. doi: 10.1016/j.jand.2017.03.024
11. Nagpal M, De D, Handa S, Pal A, Sachdeva N. Insulin resistance and metabolic syndrome in young men with acne. Journal of the American Academy of Dermatology 2016; 152 (4): 399- 404. doi:10.1001/jamadermatol.2015.4499
12. Kaymak Y, Adisen E, Ilter N, Bideci A, Gurler D, Celik B. Dietary glycemic index and glucose, insulin, insulin-like growth factor-I, insulin-like growth factor binding protein 3, and leptin levels in patients with acne. Journal of the American Academy of Dermatology 2007; 57 (5): 819-823. doi: 10.1016/j. jaad.2007.06.028
13. Balta I, Ekiz O, Ozuguz P, Ustun I, Karaca S et al. Insulin resistance in patients with post‐adolescent acne. International Journal of Dermatology 2015; 54 (6): 662-666. doi: 10.1111/ ijd.12426
14. Munichandrappa P, Manjunath K, Kiran C, Variyar A. A comparative study of insulin resistance in acne vulgaris. International Journal of Research in Dermatology 2017; 3 (3): 403-406. doi:10.18203/issn.2455-4529.IntJResDermatol 20172545
15. Samouda H, Dutour A, Chaumoitre K, Panuel M, Dutour O, Dadoun F. VAT= TAATSAAT: Innovative anthropometric model to predict visceral adipose tissue without resort to CT‐ Scan or DXA. Obesity 2013; 21 (1): E41-E50. doi: 10.1002/ oby.20033
16. Motamed N, Khonsari MR, Rabiee B, Ajdarkosh H, Hemasi GR et al. Discriminatory ability of visceral adiposity index (VAI) in diagnosis of metabolic syndrome: A population based study. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association 2017; 125 (3): 202-207. doi: 10.1055/s-0042-119032
17. Kouli GM, Panagiotakos DB, Kyrou I, Georgousopoulou EN, Chrysohoou C et al. Visceral adiposity index and 10- year cardiovascular disease incidence: the ATTICA study. Nutrition, Metabolism and Cardiovascular Diseases 2017; 27 (10): 881-889. doi: 10.1016/j.numecd.2017.06.015
18. Pekgor S, Duran C, Berberoglu U, Eryilmaz MA. The role of visceral adiposity index levels in predicting the presence of metabolic syndrome and insulin resistance in overweight and obese patients. Metabolic Syndrome and Related Disorders 2019; 17 (5): 296-302. doi: 10.1089/met.2019.0005
19. Ji B, Qu H, Wang H, Wei H, Deng H. Association between the visceral adiposity index and homeostatic model assessment of insulin resistance in participants with normal waist circumference. Angiology 2017; 68 (8): 716-721. doi: 10.1177/0003319716682120
20. Aboelnaga MM, Elshahawy H. Visceral adiposity index correlation with Rotterdam criteria in patients with polycystic ovary syndrome. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2016; 5 (8): 2553- 2560. doi: 10.18203/2320-1770.ijrcog20162623